Nebulizers in Clinical Practice: Noise, Communication, and Infection Control

COPD is common. It is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. And anyone who has worked in a hospital will know that exacerbations are common also. So it is important that we get the diagnosis and management of this condition right. To find out more details about this problem and what we can do about it, please do listen to his podcast interview with Neil Greening, Associate Professor and Honorary Consultant Physician at the Institute for Lung Health, Leicester. Competing interests: Dr Greening has received honoraria, lecture fees, travel for conferences and consultancy fees from AstraZeneca, GlaxoSmithKline, Chiesi, Sanofi and Pulmonx. His Institution has received grant funding and consultancy fees from GSK, and Roche.